Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible vision loss.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Average IOP reductions were 23.04% at 6 months and 25.74 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Dry eye prevalence based on Ocular Surface Disease Index ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and ...

Aug. 5 -- TUESDAY, Aug. 4 (HealthDay News) -- A new type of eye drop appears to protect retinal and optic nerve cells -- and even reverse some sight loss -- in patients battling glaucoma, a leading ...

NEW YORK (Reuters Health) - People in most need of sight-preserving eyedrops may be the least successful in landing the therapy in their eyes, suggests a new study. Buildup of internal eye pressure is ...

Researchers have discovered that eye drops used to treat elevated pressure inside the eye can be effective in delaying the onset of glaucoma. These results mean that treating people at higher risk for ...

Eye drops may prevent or delay the development of disease. * THE QUESTION Do eye drops protect against glaucoma in people who have high pressure in their eyes? High pressure, which develops when the ...

SHREVEPORT, La. — Glaucoma is the second leading cause of blindness. And most of the time, it has no symptoms. Dr. Chris Shelby of the WK Eye Institute explains how glaucoma is treated: “Because ...

COLUMBUS, Ohio – Glaucoma, a leading cause of blindness, may be delayed or prevented in high-risk African Americans with daily eye drops. The findings, published in this month's issue of the Archives ...